Vyleesi: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 October 2024

  • curprev 16:4116:41, 16 October 2024‎ Omid Afkhami-Ardakani talk contribs‎ 6,144 bytes +6,144‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami Ardakani |genericName=Vyleesi |aOrAn=a |drugClass=Melanocortin receptor agonist |indicationType=treatment |indication=hypoactive sexual desire disorder (HSDD) in premenopausal women |adverseReactions=nausea (40%), flushing (20%), injection site reactions (13%), headache (11%), and vomiting (4.8%) |fdaLIADAdult=Vyleesi is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in pre..."
Retrieved from "https://www.wikidoc.org/index.php/Vyleesi"